Private Equity

Private equity is in our DNA. We are the world’s leading consulting firm for the industry— with a global practice more than three times the size of our nearest competitor. PE comprises about one-third of our global business, having grown eightfold in the last 15 years. Our team of more than 2,000 private equity consultants serves clients globally, providing essential guidance on strategy, sourcing, due diligence, post-acquisition value creation, and institutional investor strategy. Our depth of expertise and strong market positioning have played a pivotal role in more than half of $500 million–plus buyout transactions globally since 2000. 

We partner with you throughout the entire investment cycle. Ensuring you have the right investment thesis and winning approach strategy, we help focus your deal generation and sector screening process. Post-acquisition, we support the pursuit of rapid returns by developing strategic blueprints for acquired companies, leading workshops that align management with strategic priorities, and directing focused initiatives.

We have helped the leading institutional investors and sovereign wealth funds develop top-performing investment programs across private equity, real estate, and infrastructure asset classes. As investors ourselves, we leverage our expertise to expand your participation in direct investing opportunities. Proprietary data tools, such as DealEdge, SPS, OPEXEngine, and Pyxis, reveal key insights and boost our best-in-class capabilities.

The private equity landscape is being reshaped by myriad forces: the rise of virtual sales, the omnipresence of digital and rapidly evolving web3 capabilities, a renewed focus on talent, and, most notably, ESG (environmental, social, and governance) investing. Leading private equity firms are meeting demand for more sustainable, socially conscious corporate behavior, weaving ESG into all operations—and gaining market share in the process.

Amid these shifts, private equity continues to supersize, with larger funds doing larger deals. With a deep bench, proven expertise, and state-of-the-art advanced analytics tools, we can help you navigate these changes and achieve superior results.

Client Results

Global Healthcare Private Equity Report 2024

This year’s report focuses on the forces creating major opportunities for investors and their portfolio companies, from generative AI to the burgeoning Indian market to innovation in life sciences.

Read the report

Featured Team Members


Stuck in Place: Private Equity Midyear Report 2023

Stalled dealmaking and exits have jammed the capital flywheel, putting a premium on liquidity.


Ready to talk?

We work with ambitious leaders who want to define the future, not hide from it. Together, we achieve extraordinary outcomes.

Vector℠ is a service mark of Bain & Company, Inc.